High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases

By Charkoudian Leon D.   Ying Gui-shuang   Pujari Siddharth S.   Gangaputra Sapna   Thorne Jennifer E.   Foster C. Stephen   Jabs Douglas A.   Levy-Clarke Grace A.   Nussenblatt Robert B.   Rosenbaum James T.   Suhler Eric B.   Kempen John H.  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 91-99

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Immunoglobulin in Patients With Anti-GAD Antibody-Associated Neurological Diseases and Patients With Inflammatory Myopathies: Effects on Clinicopathological Features and Immunoregulatory Genes

By Dalakas Marinos C.  

Clinical Reviews in Allergy and Immunology, Vol. 29, Iss. 3, 2005-12 ,pp. : 255-270

Humana Press, Inc

Access to resources Recommend Favorite

Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature

By Hefer David   Jaloudi Mohammed  

Annals of Hematology, Vol. 83, Iss. 10, 2004-10 ,pp. : 661-665

Springer Publishing Company

Access to resources Recommend Favorite

Regulation by transforming growth factor-β1 of class II mRNA and protein expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis

By Santos A.  

International Immunology, Vol. 10, Iss. 5, 1998-05 ,pp. : 601-607

Oxford University Press

Access to resources Recommend Favorite

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma

By Kishiyama J.L.   Valacer D.   Cunningham-Rundles C.   Sperber K.   Richmond G.W.   Abramson S.   Glovsky M.   Stiehm R.   Stocks J.   Rosenberg L.   Shames R.S.   Corn B.   Shearer W.T.   Bacot B.   DiMaio M.   Tonetta S.   Adelman D.C.  

Clinical Immunology, Vol. 91, Iss. 2, 1999-05 ,pp. : 126-133

Academic Press

Access to resources Recommend Favorite